chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash macular
Clinical narrative: Red blotches initially on his shin,  another outbreak of red blotches on the hips; This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (Red blotches initially on his shin,  another outbreak of red blotches on the hips) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019F21A, 025B21A and 010A21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: INFLUENZA in September 2021. Past adverse reactions to the above products included No adverse event with INFLUENZA.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced RASH MACULAR (Red blotches initially on his shin,  another outbreak of red blotches on the hips). At the time of the report, RASH MACULAR (Red blotches initially on his shin,  another outbreak of red blotches on the hips) had not resolved.            Patient medical history information included no allergies or medical conditions (both acute and chronic illness). No concomitant medications were reported. Patient was initially given a steroid cream which did nothing as treatment.   This case was linked to MOD-2022-609301 (Patient Link).
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administer an expired vaccine to a patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer an expired vaccine to a patient) in a 55-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 004M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 17-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer an expired vaccine to a patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer an expired vaccine to a patient) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment medications was reported.  It was unknown when the vial was initially stored in the refrigerator. The vial does not undergo any temperature excursions.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Nausea
Clinical narrative: I didn't feel good, but it wasn't bad; slightly nauseated; head hurt; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I didn't feel good, but it wasn't bad), NAUSEA (slightly nauseated) and HEADACHE (head hurt) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE for an unknown indication.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced FEELING ABNORMAL (I didn't feel good, but it wasn't bad), NAUSEA (slightly nauseated) and HEADACHE (head hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 23-Nov-2021, FEELING ABNORMAL (I didn't feel good, but it wasn't bad), NAUSEA (slightly nauseated) and HEADACHE (head hurt) had resolved.            It was reported that Approximately 12-14 hours after receiving 1st booster shot of the Moderna vaccine, patient started experiencing slight nausea and head was hurting. patient said that patient was not feeling well but it was not as bad as patient had felt after receiving the primary series. This time patient symptoms lasted for 1 day, after which patient felt better.   This case was linked to MOD-2021-047816, MOD-2022-609315 (Patient Link).
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Poor quality product administered, Product storage error, Product temperature excursion issue
Clinical narrative: vial underwent temperature excursions; Expired vaccine stored and administered; vaccinated someone two days after the expiration date; vaccinated someone two days after the expiration date, vial was initially stored in the refrigerator on 15Jul2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date), PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date, vial was initially stored in the refrigerator on 15Jul2022) and PRODUCT STORAGE ERROR (Expired vaccine stored and administered) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date) and POOR QUALITY PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date, vial was initially stored in the refrigerator on 15Jul2022). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent temperature excursions) and PRODUCT STORAGE ERROR (Expired vaccine stored and administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date), PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date, vial was initially stored in the refrigerator on 15Jul2022) and PRODUCT STORAGE ERROR (Expired vaccine stored and administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.              Number of doses/vials included as 4 doses (2 boosters and 2 second boosters). The vial was initially stored in the refrigerator on 15-Jul-2022. The vial underwent  temperature excursion.  No treatment information was provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Poor quality product administered, Product storage error, Product temperature excursion issue
Clinical narrative: Date the vial was initially stored in the refrigerator 15Jul2022 and date of administration of vaccine 15-jul-2022; temperature excursions; poor quality drug administered; vaccinated someone two days after the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 15Jul2022 and date of administration of vaccine 15-jul-2022), PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (poor quality drug administered) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 15Jul2022 and date of administration of vaccine 15-jul-2022), PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (poor quality drug administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 15Jul2022 and date of administration of vaccine 15-jul-2022), PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (poor quality drug administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The caller asked vaccinated someone two days after the expiration date. Number of doses/vials: 4 doses (2 boosters and 2 second boosters). The vial undergone temperature excursions. No treatment medication was reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: Patient reported an adverse event; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Patient reported an adverse event) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Patient reported an adverse event). At the time of the report, IMMUNISATION REACTION (Patient reported an adverse event) outcome was unknown.     Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter. The patient did not receive second booster of Moderna Covid-19.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error, Product temperature excursion issue
Clinical narrative: Temperature excursions; Expired vaccine stored and then administered; Vaccinated someone two days after the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccinated someone two days after the expiration date), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions) and PRODUCT STORAGE ERROR (Expired vaccine stored and then administered) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccinated someone two days after the expiration date). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions) and PRODUCT STORAGE ERROR (Expired vaccine stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccinated someone two days after the expiration date), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions) and PRODUCT STORAGE ERROR (Expired vaccine stored and then administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported. Dose administered after manufacturer date of expiry,4 doses were administered, 2 boosters and 2 second boosters. The vial was initially stored in the refrigerator on 15-Jul-2022 The vial underwent  temperature excursion. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: vial underwent temperature excursions; vaccinated someone two days after the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date) and PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent temperature excursions) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent temperature excursions). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated someone two days after the expiration date) and PRODUCT TEMPERATURE EXCURSION ISSUE (vial underwent temperature excursions) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  On an unknown date, the vial undergo temperature excursions.  On 15-Jul-2022, the vial was initially stored in the refrigerator.  The patient received 4 doses were (2 boosters and 2 second boosters).  No treatment drug details was reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Mobility decreased, Nausea, Pain
Clinical narrative: general aches and pains; malaise/not feeling well; stayed in bed; high fever; severe headache/headache was the worse of all the side effects; vomiting; nausea; This spontaneous case was reported by a patient and describes the occurrence of PAIN (general aches and pains), MALAISE (malaise/not feeling well), MOBILITY DECREASED (stayed in bed), PYREXIA (high fever) and HEADACHE (severe headache/headache was the worse of all the side effects) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A and 030A21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced PAIN (general aches and pains), MALAISE (malaise/not feeling well), MOBILITY DECREASED (stayed in bed), PYREXIA (high fever), HEADACHE (severe headache/headache was the worse of all the side effects), VOMITING (vomiting) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 08-Apr-2021, PAIN (general aches and pains), MALAISE (malaise/not feeling well), MOBILITY DECREASED (stayed in bed), PYREXIA (high fever), HEADACHE (severe headache/headache was the worse of all the side effects), VOMITING (vomiting) and NAUSEA (nausea) had resolved.            It was reported that patient had to stay in bed the whole time as was not feeling well.   This case was linked to MOD-2021-047816, MOD-2022-609304 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: general aches and pains; malaise/not feeling well; stayed in bed; high fever; severe headache/headache was the worse of all the side effects; vomiting; nausea; This spontaneous case was reported by a patient and describes the occurrence of PAIN (general aches and pains), MALAISE (malaise/not feeling well), MOBILITY DECREASED (stayed in bed), PYREXIA (high fever) and HEADACHE (severe headache/headache was the worse of all the side effects) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A and 030A21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced PAIN (general aches and pains), MALAISE (malaise/not feeling well), MOBILITY DECREASED (stayed in bed), PYREXIA (high fever), HEADACHE (severe headache/headache was the worse of all the side effects), VOMITING (vomiting) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 08-Apr-2021, PAIN (general aches and pains), MALAISE (malaise/not feeling well), MOBILITY DECREASED (stayed in bed), PYREXIA (high fever), HEADACHE (severe headache/headache was the worse of all the side effects), VOMITING (vomiting) and NAUSEA (nausea) had resolved.            It was reported that patient had to stay in bed the whole time as was not feeling well.   This case was linked to MOD-2021-047816, MOD-2022-609304 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Blood pressure measurement, Breast pain, Chromaturia
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Dyspepsia, Dyspnoea, Dysuria, Fatigue
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypersomnia, Lymph node pain, Movement disorder, Pain in extremity, Pyrexia
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sinus disorder, Tremor, Urine abnormality
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Asthma, Breast pain, COVID-19, Chills
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Drug ineffective, Dyspnoea, Lymph node pain, Pain in extremity, Pyrexia
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test, Sinus congestion
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Breast pain, Chills, Dyspnoea, Lymph node pain
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Sinus congestion
Clinical narrative: pain in right breast  travel to left; Difficulty Breathing; Sinus clogging; Pain traveled to left lymph node; pain traveled to toes; Joint pain; Fever at nights (not measured); Chills; This spontaneous case was reported by a patient and describes the occurrence of BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node) and PAIN IN EXTREMITY (pain traveled to toes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A, 022M20A and 031L20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Mar-2022. Concurrent medical conditions included Hypothyroidism and Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills). On 02-Nov-2021, BREAST PAIN (pain in right breast  travel to left), DYSPNOEA (Difficulty Breathing), SINUS CONGESTION (Sinus clogging), LYMPH NODE PAIN (Pain traveled to left lymph node), PAIN IN EXTREMITY (pain traveled to toes), ARTHRALGIA (Joint pain), PYREXIA (Fever at nights (not measured)) and CHILLS (Chills) had resolved.            Patient family history included diabetes, High blood pressure, Heart disease but she does not had these medical conditions.  It was reported that 4-6 hours later patient had pain in right breast travel to left , traveled to left lymph node then traveled to toes and joint pain.Fever at nights (not measured) chills, then sinus clogging, difficulty breathing.  No treatment medications were reported.   This case was linked to MOD-2022-609316 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, X-ray
Clinical narrative: after the 1st shot, left arm was sore; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (after the 1st shot, left arm was sore) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Patient had no allergy for medications, food and other products. Patient had not tested positive or diagnosed with COVID-19. Patient doesn't smoke.     On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (after the 1st shot, left arm was sore). At the time of the report, PAIN IN EXTREMITY (after the 1st shot, left arm was sore) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: In the middle". little bit of closing, but nothing to be concerned about..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication was reported. Patient was a runner. Took no medications and was very healthy. No treatment information was provided.   This case was linked to MOD-2022-609261 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vial stored in Refrigerator post puncture.; Patient received Moderna Covid-19 vaccine more than 12 hours after the vial had been punctured.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine more than 12 hours after the vial had been punctured.) and PRODUCT STORAGE ERROR (vial stored in Refrigerator post puncture.) in a 51-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 049L21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 25-Jan-2021, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Feb-2021, received dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2022, received dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 14-Jul-2022, received dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 14-Jul-2022,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine more than 12 hours after the vial had been punctured.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial stored in Refrigerator post puncture.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine more than 12 hours after the vial had been punctured.) and PRODUCT STORAGE ERROR (vial stored in Refrigerator post puncture.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported.  Vial was initially stored in the refrigerator on date 09Jun2022. vial did not  undergo any temperature excursions.  It was reported that Total amount of time the vial was exposed to room temperature range (8 degree Celcius  to 25 degree Celcius) Under 12 hours  No Treatment medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2022: Follow up received contain significant information. On 19-Jul-2022: Follow-up received contain Patient information and product details added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was stored in refrigerator on 10-Jun-2022 and was administered to the patient on 12-Jul-2022; Vaccine was administered to the patient after 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 10-Jun-2022 and was administered to the patient on 12-Jul-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine was administered to the patient after 30 day use by date) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered to the patient after 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 10-Jun-2022 and was administered to the patient on 12-Jul-2022). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 10-Jun-2022 and was administered to the patient on 12-Jul-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine was administered to the patient after 30 day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient weight was reported as 225.6. No concomitant medications were reported. It was reported that, the pharmacy has sent Moderna COVID-19 vaccines on 10-Jun-2022 and on the same day the vials were initially stored in refrigerator, but vaccine was given to the patient on 12-Jul-2022. The patient administered vaccine after the 30 days use date. The vials did not undergo any temperature excursions. No adverse event reported by the patient. No treatment medications were reported.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered the Moderna COVID-19 vaccine after the published expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered the Moderna COVID-19 vaccine after the published expiration date) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 17-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered the Moderna COVID-19 vaccine after the published expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered the Moderna COVID-19 vaccine after the published expiration date) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient did not report any symptoms after receiving this dose of the vaccine.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-609499 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-609499:Patient 1 (Same reporter)